PAR 3.39% 28.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm reports Positive Pre-IND meeting with US FDA

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.